Fourrts (India) Laboratories is a finished-dose manufacturer based in United Arab Emirates. It appears in 153 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with ZAMRA (ZM), TMDA (TZ) and EFDA (ET). Its GMP standing is certified by EMA, NAFDAC (NG) and MHRA (UK), among 4 authorities. Customs aggregates show $46 of exports covering 15 molecules to 2 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Kancheepuram Dist., United Arab Emirates | Not on file |
| Kelambakkam, United Arab Emirates | Not on file |
| Chennai, United Arab Emirates | Not on file |
| Chennai, India | 3016903724 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ZAMRA (ZM) | 28 | None |
| TMDA (TZ) | 25 | None |
| EFDA (ET) | 17 | None |
| EDE (AE) | 16 | None |
| NAFDAC (NG) | 15 | 1 |
| MINSA (CR) | 14 | None |
| EMA | None | 4 |
| MHRA (UK) | None | 1 |
| UZPHARM (UZ) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.2M | 18 |
| 2025 | Not reported | $46 | 2 |
| 2024 | Not reported | $20 | 1 |
| 2023 | Not reported | $121 | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Fourrts (India) Laboratories comes back tiered against every other supplier able to file there.
Start for free